A mechanism by which binding of the broadly neutralizing antibody b12 unfolds the inner domain α1 helix in an engineered HIV-1 gp120
- PMID: 21117239
- PMCID: PMC3059550
- DOI: 10.1002/prot.22901
A mechanism by which binding of the broadly neutralizing antibody b12 unfolds the inner domain α1 helix in an engineered HIV-1 gp120
Abstract
Using all-atom simulations, we examine the role of the I109C/Q428C disulfide "stitch" in altering the conformational distribution of engineered HIV-1 gp120 core relevant for binding of the broadly neutralizing recombinant antibody b12. In particular, we propose that the I109C/Q428C stitch results in a conformational distribution favoring an unfolded inner-domain α1-helix upon binding of b12. Using targeted molecular dynamics, we show that folded α1 in the b12-bound conformation of gp120 is stable both with and without the stitch, but that with folded α1, the stitch requires an orientation of the β20/β21 sheet that is sterically incompatible with b12 binding. Forcing β20/β21 into the orientation displayed by the b12-bound conformation after folding α1 with the stitch intact results in partial unfolding of α1, whereas without the stitch, β20/β21 reorientation does not affect the conformation of α1. These findings collectively support the hypothesis that the disulfide stitch shifts the conformational distribution of α1 to the unfolded state, meaning an unfolded α1 is not a strict requirement of the b12-bound conformational ensemble of gp120's lacking the I109C/Q428C stitch.
© 2010 Wiley-Liss, Inc.
Figures










Similar articles
-
Spontaneous rearrangement of the β20/β21 strands in simulations of unliganded HIV-1 glycoprotein, gp120.Biochemistry. 2012 Oct 2;51(39):7783-93. doi: 10.1021/bi300878d. Epub 2012 Sep 21. Biochemistry. 2012. PMID: 22963284 Free PMC article.
-
Structural elements of primary CCR5-using HIV-1 gp120 proteins influencing sensitivity and resistance to the broadly neutralizing monoclonal antibody b12.Virology. 2012 Oct 25;432(2):394-404. doi: 10.1016/j.virol.2012.06.024. Epub 2012 Jul 19. Virology. 2012. PMID: 22818780
-
Targeted deletion in the beta20-beta21 loop of HIV envelope glycoprotein gp120 exposes the CD4 binding site for antibody binding.Virology. 2008 Aug 1;377(2):330-8. doi: 10.1016/j.virol.2008.03.040. Epub 2008 Jun 2. Virology. 2008. PMID: 18519142
-
CD4 binding partially locks the bridging sheet in gp120 but leaves the beta2/3 strands flexible.J Mol Biol. 2005 Jul 15;350(3):514-27. doi: 10.1016/j.jmb.2005.05.009. J Mol Biol. 2005. PMID: 15946678
-
Antibody recognition of HIV and dengue glycoproteins.Glycobiology. 2016 Aug;26(8):813-9. doi: 10.1093/glycob/cww031. Epub 2016 Mar 3. Glycobiology. 2016. PMID: 26941393 Free PMC article. Review.
Cited by
-
Covalent conjugation of a peptide triazole to HIV-1 gp120 enables intramolecular binding site occupancy.Biochemistry. 2014 Jun 3;53(21):3403-14. doi: 10.1021/bi500136f. Epub 2014 May 19. Biochemistry. 2014. PMID: 24801282 Free PMC article.
-
Understanding the molecular mechanism of the broad and potent neutralization of HIV-1 by antibody VRC01 from the perspective of molecular dynamics simulation and binding free energy calculations.J Mol Model. 2012 Sep;18(9):4517-27. doi: 10.1007/s00894-012-1450-z. Epub 2012 May 29. J Mol Model. 2012. PMID: 22643972
-
Targeting a Neutralizing Epitope of HIV Envelope Gp120 by Immune Complex Vaccine.J AIDS Clin Res. 2012 Mar 9;S8(2):5512. doi: 10.4172/2155-6113.S8-002. J AIDS Clin Res. 2012. PMID: 22891160 Free PMC article.
References
-
- Poignard P, Saphire E, Parren P, Burton D. Gp120: Biologic aspects of structural features. Annu Rev Immunol. 2001;19:253–274. - PubMed
-
- Phogat S, Wyatt R. Rational modifications of hiv-1 envelope glycoproteins for immunogen design. Curr Pharm Design. 2007;13:213–227. - PubMed
-
- Wyatt R, Sodroski J. The hiv-1 envelope glycoproteins: Fusogens, antigens, and immunogens. Science. 1998;280:1884–1888. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources